Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jon Petur Joelsson"'
Autor:
Jon Petur Joelsson, Arni Asbjarnarson, Snaevar Sigurdsson, Jennifer Kricker, Bryndis Valdimarsdottir, Holmfridur Thorarinsdottir, Eir Starradottir, Thorarinn Gudjonsson, Saevar Ingthorsson, Sigurbergur Karason
Publikováno v:
Laboratory Animal Research, Vol 38, Iss 1, Pp 1-15 (2022)
Abstract Background Mechanical ventilation is a life-saving therapy for critically ill patients, providing rest to the respiratory muscles and facilitating gas exchange in the lungs. Ventilator-induced lung injury (VILI) is an unfortunate side effect
Externí odkaz:
https://doaj.org/article/72de43d601f14dc88678df500648563b
Autor:
Jon Petur Joelsson, Saevar Ingthorsson, Jennifer Kricker, Thorarinn Gudjonsson, Sigurbergur Karason
Publikováno v:
Laboratory Animal Research, Vol 37, Iss 1, Pp 1-11 (2021)
Abstract Ventilator-induced lung injury (VILI) is a serious acute injury to the lung tissue that can develop during mechanical ventilation of patients. Due to the mechanical strain of ventilation, damage can occur in the bronchiolar and alveolar epit
Externí odkaz:
https://doaj.org/article/b90051c7044b44fb9080169462e24f79
Autor:
Alexander Schepsky, Gunnhildur Asta Traustadottir, Jon Petur Joelsson, Sævar Ingthorsson, Jennifer Kricker, Jon Thor Bergthorsson, Arni Asbjarnarson, Thorkell Gudjonsson, Nina Nupponen, Ana Slipicevic, Fredrik Lehmann, Thorarinn Gudjonsson
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6726-6738 (2020)
Abstract Melphalan flufenamide (hereinafter referred to as “melflufen”) is a peptide‐conjugated drug currently in phase 3 trials for the treatment of relapsed or refractory multiple myeloma. Due to its lipophilic nature, it readily enters cells
Externí odkaz:
https://doaj.org/article/5b8204561d5640db964aa4eb74a5b510
Autor:
Jon Petur Joelsson, Jennifer A. Kricker, Ari J. Arason, Snaevar Sigurdsson, Bryndis Valdimarsdottir, Fridrik Runar Gardarsson, Clive P. Page, Fredrik Lehmann, Thorarinn Gudjonsson, Saevar Ingthorsson
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background The airway epithelium (AE) forms the first line of defence against harmful particles and pathogens. Barrier failure of the airway epithelium contributes to exacerbations of a range of lung diseases that are commonly treated with A
Externí odkaz:
https://doaj.org/article/68af876a3a5d4feaab0da207655852e8
Autor:
Ari Jon Arason, Jon Petur Joelsson, Bryndis Valdimarsdottir, Snaevar Sigurdsson, Alexander Gudjonsson, Skarphedinn Halldorsson, Freyr Johannsson, Ottar Rolfsson, Fredrik Lehmann, Saevar Ingthorsson, Paulina Cherek, Gudmundur H. Gudmundsson, Fridrik R. Gardarsson, Clive P. Page, Olafur Baldursson, Thorarinn Gudjonsson, Jennifer A. Kricker
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-19 (2019)
Abstract Background Azithromycin (Azm) is a macrolide recognized for its disease-modifying effects and reduction in exacerbation of chronic airway diseases. It is not clear whether the beneficial effects of Azm are due to its anti-microbial activity
Externí odkaz:
https://doaj.org/article/c8da4be92fa246189c8660fe3fd024d1
Autor:
Bryndis Valdimarsdottir, Saevar Ingthorsson, Jennifer A. Kricker, Ari Jon Arason, Snaevar Sigurdsson, Fridrik Runar Gardarsson, Clive P. Page, Thorarinn Gudjonsson, Jon Petur Joelsson, Fredrik Lehmann
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-11 (2020)
Respiratory Research
Respiratory Research
Publisher's version (útgefin grein)
Background: The airway epithelium (AE) forms the first line of defence against harmful particles and pathogens. Barrier failure of the airway epithelium contributes to exacerbations of a range of lung disease
Background: The airway epithelium (AE) forms the first line of defence against harmful particles and pathogens. Barrier failure of the airway epithelium contributes to exacerbations of a range of lung disease
Autor:
Jennifer A. Kricker, Jon Petur Joelsson, Sigurbergur Karason, Saevar Ingthorsson, Thorarinn Gudjonsson
Publikováno v:
Laboratory Animal Research
Laboratory Animal Research, Vol 37, Iss 1, Pp 1-11 (2021)
Laboratory Animal Research, Vol 37, Iss 1, Pp 1-11 (2021)
Ventilator-induced lung injury (VILI) is a serious acute injury to the lung tissue that can develop during mechanical ventilation of patients. Due to the mechanical strain of ventilation, damage can occur in the bronchiolar and alveolar epithelium re
Autor:
Fredrik Lehmann, Jennifer A. Kricker, Clive P. Page, Fridrik Runar Gardarsson, Ari Jon Arason, Jon Petur Joelsson, Thorarinn Gudjonsson, Bryndis Valdimarsdottir, Saevar Ingthorsson
Publikováno v:
Airway pharmacology and treatment.
Azithromycin (AZM) is a macrolide which is effective in the treatment of several airway diseases induced by bacterial or environmental insults. We have previously shown barrier enhancing effects of AZM on airway epithelium (AE). In order to analyze b
Autor:
Sergiu P. Paşca, Cristina D. Vlad, Grigore Gafencu, Rares Stiufiuc, Ciprian Tomuleasa, Bobe Petrushev, Stefan O. Ciurea, Anca Onaciu, Patric Teodorescu, Ancuta Jurj, Gabriel Ghiaur, Jon Petur Joelsson, Minodora Desmirean, Cristian Berce, Adrian Bogdan Tigu, Sonia Selicean, Jon Thor Bergthorsson, Raluca Munteanu, Alina-Andreea Zimta, Delia Dima, Mihail Buse, Cristian Moldovan
Publikováno v:
Journal of Cellular and Molecular Medicine
Publisher's version (útgefin grein)
Primary myelofibrosis (PMF) is a Ph-negative myeloproliferative neoplasm (MPN), characterized by advanced bone marrow fibrosis and extramedullary haematopoiesis. The bone marrow fibrosis results from excessiv
Primary myelofibrosis (PMF) is a Ph-negative myeloproliferative neoplasm (MPN), characterized by advanced bone marrow fibrosis and extramedullary haematopoiesis. The bone marrow fibrosis results from excessiv
Autor:
Clive P. Page, Thorarinn Gudjonsson, Snaevar Sigurdsson, Fredrik Lehmann, Iwona T Myszor, Sigurbergur Karason, Jon Petur Joelsson, Gudmundur H. Gudmundsson
Publikováno v:
ALTEX. 37(4)
Azithromycin (AZM) is a broad-spectrum antibiotic widely used to treat infections. AZM also has been shown to have anti-inflammatory and immunomodulatory functions unrelated to its antibacterial activity that contribute to the effectiveness of this d